Form 4: Director Michael Garnreiter Receives Axon Stock Grant

Sentiment:

Statement of Changes in Beneficial Ownership


Axon Enterprise director Michael Garnreiter acquired 658 shares of common stock via restricted stock unit grants.

Summary

  • Director Michael Garnreiter was granted 611 and 47 shares of Axon Enterprise common stock.
  • The shares were issued as time-vested restricted stock units under the 2022 Stock Incentive Plan.
  • The total beneficial ownership for the director increased to 18,398 shares following these transactions.
  • The grants are scheduled to vest on the earlier of the one-year anniversary of the grant date or the 2027 Annual Meeting of Shareholders.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of market impact.

Positives

  • Alignment of director interests with shareholders through equity-based compensation.

Negatives

  • None identified.

Risks

  • Standard market risks associated with equity ownership.

Future Outlook

The restricted stock units are set to vest in full on the earlier of the one-year anniversary of the grant date or the date of the 2027 Annual Meeting of Shareholders.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to incentivize long-term performance and align board members with shareholder value creation.

Comparison to Industry Standards

  • The use of time-vested restricted stock units for director compensation is consistent with standard practices among S&P 500 technology and security firms.
  • The vesting schedule tied to annual meetings is a common mechanism to ensure board continuity and commitment.

Stakeholder Impact

  • Minimal impact on shareholders as these are standard equity-based compensation grants.

Next Steps

  • Vesting of the granted restricted stock units on the earlier of the one-year anniversary or the 2027 Annual Meeting.

Key Dates

DateDescription
05/29/2026Date of the restricted stock unit grant transactions.
06/01/2026Date of filing for the Form 4.

Keywords

Axon Enterprise, AXON, Form 4, Insider Trading, Director Compensation, Restricted Stock Units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.